Background Toxoplasma gondii is an apicomplexan parasite that affects the health of humans and livestock, effective vaccine urgently required. Nanoparticles can modulate improve cellular humoral immune responses. Methods In current study, poly (D, L-lactic-co-glycolic acid) (PLGA) nanoparticles were used as a delivery system for T. dense granule antigens GRA12 GRA7. BALB/c mice injected with va...

This paper reports a high-yield synthesis of Ag nanospheres made up of primary nanoparticles. The size of the silver nanospheres can be controlled by changing the concentration of poly(vinylpyrrolidone) (PVP) which acts as a stabilizer. In addition, the surface morphology of the nanospheres can be well controlled through controlling the shape of primary Ag nanoparticles by introducing a small q...

It is hypothesized that the bioavailability of αT (alphatocopherol), an antioxidant, can be improved when delivered by poly(lactic-co-glycolic) acid (PLGA) nanopar‐ ticles (NPs) and chitosan covered PLGA nanoparticles (PLGA-Chi NPs), and that the mucoadhesive properties of chitosan may enhance absorption of αT. PLGA and PLGAChi NPs were characterized by measuring entrapment efficiency, size, po...

Three types of nanoparticle formulation from biodegradable PLGA-TPGS random copolymer were developed in this research for oral administration of anticancer drugs, which include DMAB-modified PLGA nanoparticles, unmodified PLGA-TPGS nanoparticles and DMAB-modified PLGA-TPGS nanoparticles. Firstly, the PLGA-TPGS random copolymer was synthesized and characterized. DMAB was used to increase retenti...

Low molecular weight chitosan (LMWC) is a promising polymer for surface modification of nanoparticles (NPs), which can impart both stealth effect and electrostatic interaction with cells at mildly acidic pH of tumors. We previously produced LMWC-coated NPs via covalent conjugation to poly(lactic-co-glycolic) acid (PLGA-LMWC NPs). However, this method had several weaknesses including inefficienc...

Glioblastoma multiforme (GBM), the most prevalent and malignant form of a primary brain tumour, is resistant to chemotherapy. In this study, we concurrently loaded three chemotherapeutic agents [bis-chloroethylnitrosourea, irinotecan, and cisplatin; BIC] into 50:50 poly[(d,l)-lactide-co-glycolide] (PLGA) nanofibres and an antiangiogenic agent (combretastatin) into 75:25 PLGA nanofibres [BIC and...

The objective of this study is to develop a sustained release system of small interfering RNA (siRNA) inside cells aiming at a prolonged time period of gene suppression. Gelatin aqueous solution containing luciferase siRNA was coacelvated by acetone addition, followed by the glutaraldehyde (GA) crosslinking of gelatin to prepare gelatin nanospheres incorporating siRNA. The nanospheres were degr...

A systematic study for the preparation and structural analysis of poly(styrene-co-acrylic acid) composite nanospheres (PSA) and silver nanoparticles loaded poly(styrene-co-acrylic acid) composite nanospheres (nAg@PSA) is reported. Poly(styrene-co-acrylic acid) nanospheres were synthesized by soap-free emulsion polymerization of styrene (St) and acrylic acid (AA) in water. Ag nanoparticles (Ag-N...

BACKGROUND This study was performed to develop a functional poly(D,L-lactide-co-glycolide)-poly(ethylene glycol) (PLGA-PEG)-bearing amino-active end group for peptide conjugation. METHODS AND RESULTS PLGA was preactivated following by copolymerization with PEG diamine. The resulting amphiphilic PLGA-PEG copolymer bearing 97.0% of amino end groups had a critical micelle concentration of 3.0 × ...